vs
太平洋生物科学（ASMB）与FLEXIBLE SOLUTIONS INTERNATIONAL INC（FSI）财务数据对比。点击上方公司名可切换其他公司
太平洋生物科学的季度营收约是FLEXIBLE SOLUTIONS INTERNATIONAL INC的1.2倍（$10.8M vs $9.1M），FLEXIBLE SOLUTIONS INTERNATIONAL INC净利率更高（-5.1% vs -85.2%，领先80.2%），太平洋生物科学同比增速更快（57.6% vs -0.5%），FLEXIBLE SOLUTIONS INTERNATIONAL INC自由现金流更多（$-4.0M vs $-15.2M）
该公司是一家成立于2004年的美国生物科技企业，主要研发生产基因测序相关设备，同时也开展新型实时生物观测技术相关业务。目前拥有两大核心测序平台，分别是基于零模波导特性的单分子实时测序平台，以及结合天然核苷酸无痕连接技术的结合测序平台。
Flexible Solutions International Inc是一家专注研发生产特种化学品的企业，核心产品包括水体蒸发抑制剂、农作物增产助剂、泳池保温剂等，服务北美及全球农业、水务领域客户。
ASMB vs FSI — 直观对比
营收规模更大
ASMB
是对方的1.2倍
$9.1M
营收增速更快
ASMB
高出58.1%
-0.5%
净利率更高
FSI
高出80.2%
-85.2%
自由现金流更多
FSI
多$11.1M
$-15.2M
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $10.8M | $9.1M |
| 净利润 | $-9.2M | $-460.9K |
| 毛利率 | — | 29.4% |
| 营业利润率 | -100.9% | 11.6% |
| 净利率 | -85.2% | -5.1% |
| 营收同比 | 57.6% | -0.5% |
| 净利润同比 | 4.3% | -167.8% |
| 每股收益（稀释后） | $-0.72 | $-0.03 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASMBFSI
| Q4 25 | — | $9.1M | ||
| Q3 25 | $10.8M | $10.6M | ||
| Q2 25 | $9.6M | $11.4M | ||
| Q1 25 | $9.4M | $7.5M | ||
| Q4 24 | $7.4M | $9.2M | ||
| Q3 24 | $6.8M | $9.3M | ||
| Q2 24 | $8.5M | $10.5M | ||
| Q1 24 | $5.8M | $9.2M |
净利润ASMBFSI
| Q4 25 | — | $-460.9K | ||
| Q3 25 | $-9.2M | $-503.4K | ||
| Q2 25 | $-10.2M | $2.0M | ||
| Q1 25 | $-8.8M | $-277.7K | ||
| Q4 24 | — | $679.6K | ||
| Q3 24 | $-9.6M | $611.9K | ||
| Q2 24 | $-11.2M | $1.3M | ||
| Q1 24 | $-9.1M | $457.2K |
毛利率ASMBFSI
| Q4 25 | — | 29.4% | ||
| Q3 25 | — | 23.9% | ||
| Q2 25 | — | 47.4% | ||
| Q1 25 | — | 26.1% | ||
| Q4 24 | — | 29.2% | ||
| Q3 24 | — | 40.9% | ||
| Q2 24 | — | 37.4% | ||
| Q1 24 | — | 30.6% |
营业利润率ASMBFSI
| Q4 25 | — | 11.6% | ||
| Q3 25 | -100.9% | 2.9% | ||
| Q2 25 | -115.2% | 29.0% | ||
| Q1 25 | -105.5% | -0.9% | ||
| Q4 24 | — | 9.4% | ||
| Q3 24 | -160.1% | 20.5% | ||
| Q2 24 | -143.0% | 18.7% | ||
| Q1 24 | -185.5% | 8.3% |
净利率ASMBFSI
| Q4 25 | — | -5.1% | ||
| Q3 25 | -85.2% | -4.8% | ||
| Q2 25 | -105.9% | 17.8% | ||
| Q1 25 | -93.6% | -3.7% | ||
| Q4 24 | — | 7.4% | ||
| Q3 24 | -140.4% | 6.6% | ||
| Q2 24 | -130.7% | 12.3% | ||
| Q1 24 | -156.9% | 5.0% |
每股收益（稀释后）ASMBFSI
| Q4 25 | — | $-0.03 | ||
| Q3 25 | $-0.72 | $-0.04 | ||
| Q2 25 | $-1.33 | $0.15 | ||
| Q1 25 | $-1.17 | $-0.02 | ||
| Q4 24 | — | $0.05 | ||
| Q3 24 | $-1.51 | $0.05 | ||
| Q2 24 | $-1.98 | $0.10 | ||
| Q1 24 | $-1.66 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $22.5M | — |
| 总债务越低越好 | — | $4.4M |
| 股东权益账面价值 | $182.7M | $38.9M |
| 总资产 | $240.0M | $61.8M |
| 负债/权益比越低杠杆越低 | — | 0.11× |
8季度趋势，按日历期对齐
现金及短期投资ASMBFSI
| Q4 25 | — | — | ||
| Q3 25 | $22.5M | — | ||
| Q2 25 | $24.0M | $10.0M | ||
| Q1 25 | $23.4M | $11.0M | ||
| Q4 24 | $38.3M | $10.0M | ||
| Q3 24 | $28.5M | $13.0M | ||
| Q2 24 | $19.2M | $9.2M | ||
| Q1 24 | $18.7M | $8.3M |
总债务ASMBFSI
| Q4 25 | — | $4.4M | ||
| Q3 25 | — | $7.1M | ||
| Q2 25 | — | $7.5M | ||
| Q1 25 | — | $8.1M | ||
| Q4 24 | — | $8.8M | ||
| Q3 24 | — | $9.4M | ||
| Q2 24 | — | $8.3M | ||
| Q1 24 | — | $8.0M |
股东权益ASMBFSI
| Q4 25 | — | $38.9M | ||
| Q3 25 | $182.7M | $39.0M | ||
| Q2 25 | $18.1M | $39.4M | ||
| Q1 25 | $27.1M | $38.4M | ||
| Q4 24 | $33.4M | $38.0M | ||
| Q3 24 | $26.0M | $36.9M | ||
| Q2 24 | $34.7M | $36.2M | ||
| Q1 24 | $32.6M | $36.0M |
总资产ASMBFSI
| Q4 25 | — | $61.8M | ||
| Q3 25 | $240.0M | $58.4M | ||
| Q2 25 | $80.8M | $58.2M | ||
| Q1 25 | $99.0M | $61.7M | ||
| Q4 24 | $119.2M | $60.0M | ||
| Q3 24 | $100.3M | $57.8M | ||
| Q2 24 | $115.3M | $56.3M | ||
| Q1 24 | $119.9M | $57.6M |
负债/权益比ASMBFSI
| Q4 25 | — | 0.11× | ||
| Q3 25 | — | 0.18× | ||
| Q2 25 | — | 0.19× | ||
| Q1 25 | — | 0.21× | ||
| Q4 24 | — | 0.23× | ||
| Q3 24 | — | 0.25× | ||
| Q2 24 | — | 0.23× | ||
| Q1 24 | — | 0.22× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-15.1M | $-3.0M |
| 自由现金流经营现金流 - 资本支出 | $-15.2M | $-4.0M |
| 自由现金流率自由现金流/营收 | -140.7% | -44.3% |
| 资本支出强度资本支出/营收 | 0.4% | 11.7% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-591.7K |
8季度趋势，按日历期对齐
经营现金流ASMBFSI
| Q4 25 | — | $-3.0M | ||
| Q3 25 | $-15.1M | $2.0M | ||
| Q2 25 | $-16.8M | $5.3M | ||
| Q1 25 | $-23.4M | $-544.3K | ||
| Q4 24 | $-51.1M | $-2.2M | ||
| Q3 24 | $-15.2M | $2.5M | ||
| Q2 24 | $-17.1M | $5.9M | ||
| Q1 24 | $-18.4M | $-604.8K |
自由现金流ASMBFSI
| Q4 25 | — | $-4.0M | ||
| Q3 25 | $-15.2M | $39.4K | ||
| Q2 25 | — | $4.3M | ||
| Q1 25 | — | $-898.4K | ||
| Q4 24 | $-51.1M | $-4.3M | ||
| Q3 24 | — | $1.3M | ||
| Q2 24 | $-17.1M | $4.7M | ||
| Q1 24 | $-18.4M | $-1.1M |
自由现金流率ASMBFSI
| Q4 25 | — | -44.3% | ||
| Q3 25 | -140.7% | 0.4% | ||
| Q2 25 | — | 37.9% | ||
| Q1 25 | — | -12.0% | ||
| Q4 24 | -695.2% | -47.0% | ||
| Q3 24 | — | 13.6% | ||
| Q2 24 | -200.6% | 44.9% | ||
| Q1 24 | -317.7% | -11.7% |
资本支出强度ASMBFSI
| Q4 25 | — | 11.7% | ||
| Q3 25 | 0.4% | 18.7% | ||
| Q2 25 | 0.0% | 8.6% | ||
| Q1 25 | 0.0% | 4.7% | ||
| Q4 24 | 0.4% | 22.8% | ||
| Q3 24 | 0.0% | 13.0% | ||
| Q2 24 | 0.2% | 11.3% | ||
| Q1 24 | 0.2% | 5.2% |
现金转化率ASMBFSI
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 2.60× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -3.27× | ||
| Q3 24 | — | 4.05× | ||
| Q2 24 | — | 4.59× | ||
| Q1 24 | — | -1.32× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
